Basit öğe kaydını göster

dc.contributor.authorÖzay, C.
dc.contributor.authorKaragür, E.R.
dc.contributor.authorAkça, H.
dc.contributor.authorMammadov, R.
dc.date.accessioned2020-11-20T17:17:08Z
dc.date.available2020-11-20T17:17:08Z
dc.date.issued2020
dc.identifier.issn1995-7157
dc.identifier.urihttps://hdl.handle.net/20.500.12809/6269
dc.description.abstractCyclamen L., belonging to the Primulaceae family, is a tuberous perennial geophyte with some taxa indigenous to Turkey. However, this genus has been poorly investigated for its cytotoxic and anticancer potentials. The current study aimed to explore the antiproliferative effects of the ethanolic extracts of three Cyclamen taxa (C. pseudibericum, C. mirabile and C. persicum) and their nitric oxide (NO) inhibitory activity in LPS-stimulated non-small cell lung cancer (NSCLC) cell lines, namely HCC78 and H1975. Also, total saponin contents of the extracts were determined as quillaja equivalents. The cytotoxicity of the Cyclamen extracts was assessed by the CellTiter-Glo assay. C. persicum extract caused a higher cytotoxic effect on both H1975 and HCC78 cells than the other two Cyclamen extracts and its IC50 values in H1975 and HCC78 cells were determined to be 17.27 and 34.15 ?g/ mL, respectively. While Griess reaction was performed to determine the nitrite levels as an index of NO production in LPS-stimulated NSCLC cells treated with the Cyclamen extracts, vanillin-sulphuric acid method was used to detect total saponin contents in the extracts. Among the three Cyclamen taxa evaluated, the highest inhibitory activity towards NO production in HCC78 cells was obtained with from C. pseudibericum, while C. persicum showed the highest inhibitory activity in H1975 cells. As a result, this study demonstrated that the tuber extracts of three Cyclamen taxa, which have been determined their total saponin contents, had significant cytotoxic activity and NO inhibitory potentials against HCC78 and H1975 non-small cell lung cancer cell lines. These data suggest that Cyclamen L. extracts examined in this study merit further research so as to isolate the bioactive secondary metabolites with anti-tumor potentials. © 2020 DSR Publishers/The University of Jordan. All Rights Reserved.en_US
dc.item-language.isoengen_US
dc.publisherUniversity of Jordan,Deanship of Scientific Researchen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCyclamenen_US
dc.subjectCytotoxicityen_US
dc.subjectLPSen_US
dc.subjectNitric oxideen_US
dc.subjectNSCLC cell linesen_US
dc.titleCyclamen l. Inhibits nitric oxide production in lps-stimulated nsclc cellsen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTempÖzay, C., Izmir Katip Celebi University, Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Izmir, Turkey; Karagür, E.R., Pamukkale University, Faculty of Medicine, Department of Medical Genetics, Denizli, Turkey; Akça, H., Pamukkale University, Faculty of Medicine, Department of Medical Genetics, Denizli, Turkey; Mammadov, R., Muğla Sıtkı Koçman University, Faculty of Science, Department of Molecular Biology and Genetics, Muğla, Turkeyen_US
dc.identifier.volume13en_US
dc.identifier.issue3en_US
dc.identifier.startpage257en_US
dc.identifier.endpage264en_US
dc.relation.journalJordan Journal of Pharmaceutical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster